Burcon to Present at 9th Annual LD Micro Invitational Conference, June 4-5, 2019 05/29/2019

VANCOUVER, BC, and Bel-Air, Calif. May 29, 2019 — Burcon NutraScience Corporation (TSX: BU), a global leader in developing functionally and nutritionally valuable plant-proteins, has been invited to present at the 9th Annual LD Micro Invitational Conference being held on June 4-5, 2019 at the Luxe Sunset Hotel in Bel-Air, California.

Burcon CEO, Johann Tergesen, is scheduled to present on June 4, 2019 at 9:00 am PT.  He will be discussing Burcon’s recently announced plans to build a $65 million (US$48.4 million) pea and canola protein processing plant.  The plant will produce unique, highly purified pea and canola protein ingredients utilizing Burcon’s patented technologies.

The launch of the pea and canola protein processing plant comes at a time when companies like Beyond Meat and Impossible Foods are raising large sums in order to expand their operations and keep up with demand.  According to industry researchers, the global plant-based protein ingredients market is growing at compounded annual rate of 5.7% and is expected to reach US$16.3 billion by 2025.

The event is one of the nation’s largest independent conferences for small/micro-cap companies, with more than 250 names presenting to more than 1,000 attendees. The conference will also feature a variety of speakers and panelists discussing topics of interest to investors and issuers. 

To schedule a one-on-one meeting with Burcon, you may submit your request online via the link provided upon registration.  To register for the conference, contact David Scher at or visit

For questions about the company, contact Paul Lam at (604) 733-0896 or email


About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually. In 2015, LD Micro launched the first pure microcap index to exclusively provide intraday information on the entire sector. LD provides tools for the benefit of everyone in the small and microcap universe. To register and attend the event, please visit


About Burcon NutraScience Corporation

Burcon is a leader in developing functionally and nutritionally valuable plant proteins. The company has developed an extensive portfolio of composition, application, and process patents originating from a core protein extraction and purification technology.  Burcon’s CLARISOY® soy protein — under license to the Archer Daniels Midland Company — offers clarity and high-quality protein nutrition for low-pH beverage systems, and excellent solubility and exceptionally clean flavour at any pH; Peazazz® is a uniquely soluble and clean-tasting pea protein; and Puratein®, Supertein® and Nutratein® are canola protein isolates with exceptional functionality and valuable nutritional profiles. For more information about the company, visit


 The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward- looking statements or forward-looking information can be identified by words such as “anticipate,” “intend,” “plan,” “goal,” “project,” “estimate,” “expect,” “believe”, “future,” “likely,” “may,” “should,” “could”, “will” and similar references to future periods. All statements other than statements of historical fact included in this release are forward-looking statements, including, without limitation, statements regarding expectations, intentions and plans contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon’s plans and expectations include the actual results of business negotiations, marketing activities, adverse general economic, market or business conditions, regulatory changes and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled “Risk Factors” in Burcon’s annual information form dated June 18, 2018 filed with the Canadian securities administrators on  Any forward-looking statement or information only speaks as of the date on which it was made and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and accordingly, investors should not rely on such statements.

 CLARISOY is a trademark of Archer Daniels Midland Company.


Investor Contact:

Paul Lam

Manager, Business Development

Burcon NutraScience Corporation

Tel (604) 733-0896, Toll-free (888) 408-7960


Media Contact:

Steve Campbell, APR


Campbell & Company Public Relations

Tel (604) 888-5267